Skip to content

The effect of decapeptile on treatment of infertile women in ICSI(Intracytoplasmic Sperm Injection) cycles

Efficacy of gonadotropin-releasing hormone agonist addition for luteal phase support in women with repeated implantation failure undergoing intracytoplasmic sperm injection cycles

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012111111430N1
Enrollment
100
Registered
2013-04-17
Start date
2013-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility, unspecified

Interventions

Intervention 1: Six days after ovum pick up single dose of 0.1 mg Decapeptile-S.C (Intervention group). Intervention 2: There is no intervention in control group.
Treatment - Drugs
Six days after ovum pick up single dose of 0.1 mg Decapeptile-S.C (Intervention group)

Sponsors

Reaserch center of Avicenna
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion: couples with two or more IVF Failure with good quality embryo transfer; women with antagonist cycle; women with at least one embryo for transfer; women under IVF wiht ones gamet and women under 42 years. Exclusion criteria: cycles with preimplantation genetic diagnosis; women with anatomical uterine disorders or hydrosalpinx and women with thyroid disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pregnancy. Timepoint: Ten days, 3 weeks, 3 months and 5 months after. Method of measurement: HCG, sonography, follow up.

Secondary

MeasureTime frame
Abortion. Timepoint: every 3 months. Method of measurement: sonography-follow up.;Twin pregnancy. Timepoint: Vaginal ultrasonography in 6-8 weeks. Method of measurement: Number of gestational sacs.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimin.Zafardoust

Infertility and recurrent pregnancy loss center of Avecinna

siminzafardoost@yahoo.com+98 21 2264 4701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026